Chemizon to Provide Array BioPharma with Chemistry Services
News Oct 18, 2007
Chemizon has announced that it has signed an agreement with Array BioPharma to provide Array with various medicinal chemistry services including chemical synthesis and new route research. Chemizon’s technical team will support Array’s internal chemistry capabilities, providing Array with a reliable, external partner to meet aggressive timelines.
“Chemizon is a professional organization with high caliber scientists and excellent facilities. We expanded our relationship with Chemizon to rapidly and cost-effectively progress our internal drug discovery programs,” said Kevin Koch, Ph.D., President and Chief Scientific Officer, Array BioPharma.
“Array is a world class drug discovery company and we are delighted that they chose Chemizon as their medicinal chemistry partner,” said Tony Piscopio, Ph.D., the Chairman and CEO of Chemizon Inc. “In the past 20 months, Chemizon has made rapid strides, both in terms of people and capabilities. The principal reason for this growth has been due to satisfied partners like Array.”
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell TypesNews
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.READ MORE
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE
BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences ProductsNews
BOC Sciences continues to add more publication items that used BOC Sciences products in their researches to its already existing collection.READ MORE